High-density lipoprotein loses its anti-inflammatory properties during acute influenza A infection

被引:11
作者
Van Lenten, BJ
Wagner, AC
Nayak, DP
Hama, S
Navab, M
Fogelman, AM
机构
[1] Univ Calif Los Angeles, Sch Med, Dept Med, Div Cardiol, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Sch Med, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA
关键词
arteriosclerosis; infection; lipoproteins; mice; myocardial infarction;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Viruses have been identified as one of a variety of potential agents that are implicated in atherogenesis. Methods and Results-C57BL/6J mice were killed before or 2, 3, 5, 7, or 9 days after intranasal infection with 10(5) plaque-forming units (pfu) of Influenza A strain WSN/33. Peak infectivity in lungs was reached by 72 hours, and it returned to baseline by 9 days. No viremia was observed at any time. The activities of paraoxonase and platelet-activating factor acetylhydrolase in HDL decreased after infection and reached their lowest levels 7 days after inoculation. The ability of HDL from infected mice to inhibit LDL oxidation and LDL-induced monocyte chemotactic activity in human artery wall cell cocultures decreased with time after inoculation. Moreover, as the infection progressed, LDL more readily induced monocyte chemotaxis. Peak interleukin-6 and serum amyloid A plasma levels were observed at 2 and 7 days after inoculation. HDL apoA-I levels did not change. ApoJ and ceruloplasmin levels in HDL peaked 3 days after infection. Ceruloplasmin remained elevated throughout the time course, whereas apoJ levels decreased toward baseline after the third day. Conclusions-We conclude that alterations in the relative levels of paraoxonase, platelet-activating factor acetylhydrolase, ceruloplasmin, and apoJ in HDL occur during acute influenza infection, causing HDL to lose its anti-inflammatory properties.
引用
收藏
页码:2283 / 2288
页数:6
相关论文
共 33 条
[1]   A SPECTROPHOTOMETRIC MICROTITER-BASED ASSAY FOR THE DETECTION OF HYDROPEROXY DERIVATIVES OF LINOLEIC-ACID [J].
AUERBACH, BJ ;
KIELY, JS ;
CORNICELLI, JA .
ANALYTICAL BIOCHEMISTRY, 1992, 201 (02) :375-380
[2]   Vaccines against human cytomegalovirus: Time to test [J].
Britt, WJ .
TRENDS IN MICROBIOLOGY, 1996, 4 (01) :34-38
[3]  
BRONZERT TJ, 1977, CLIN CHEM, V23, P2089
[4]  
CABANA VG, 1989, J LIPID RES, V30, P39
[5]  
de la Llera Moya M, 1994, ARTERIOSCLER THROMB, V14, P1056
[6]   INTACT HUMAN CERULOPLASMIN OXIDATIVELY MODIFIES LOW-DENSITY-LIPOPROTEIN [J].
EHRENWALD, E ;
CHISOLM, GM ;
FOX, PL .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (04) :1493-1501
[7]  
FOGELMAN AM, 1988, J LIPID RES, V29, P1243
[8]   Mechanisms of disease: Acute-phase proteins and other systemic responses to inflammation [J].
Gabay, C ;
Kushner, I .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (06) :448-454
[9]  
GAN KN, 1991, DRUG METAB DISPOS, V19, P100
[10]  
García-Sastre A, 1998, J VIROL, V72, P8550